Khan et al
168 However, the possibility of DDIs related to delayed gastric emptying cannot be excluded, 175 so investigators recommend monitoring when oral drugs are co-administered with GLP-1 RAs and a dual GLP-1/GIP RA
To establish bioequivalence, the estimated treatment ratio should be fully contained within 0.80001.2500 and the 95% upper CI for ( T R ) 2 S 2 WR , based on Howes approximation, should be 0
Takashima S, Fujita H, Fujishima H, Shimizu T, Sato T, Morii T, Tsukiyama K, Narita T, Takahashi T, Drucker DJ, Seino Y, Yamada Y
The development of novel delivery systems, such as oral formulations that bypass the digestive enzymes, ensures the drugs retain their efficacy while providing a user-friendly option
How Does Fat Transfer Complement Liposuction For Post-GLP-1 Patients